Could a Two-Drug cocktail replace triple therapy for heart stent patients?
NCT ID NCT04695106
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a two-drug combination of dabigatran and ticagrelor can lower bleeding risk compared to the standard three-drug therapy (dabigatran, clopidogrel, and aspirin) in people with atrial fibrillation who have had a heart stent after a heart attack. About 1,200 participants will receive either the dual or triple therapy for 12 months. The goal is to see if the dual therapy is at least as safe and effective at preventing clots and strokes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Dabigatran and ticagrelor (blood thinners)
What this could lead to
If successful, this could offer a safer, simpler two-drug regimen that lowers bleeding risk while still protecting against clots and strokes in patients with atrial fibrillation and recent heart stents.
What could go wrong
This is a Phase 4 non-inferiority trial, meaning it aims to show the new combo is at least as safe as current care, not necessarily better. Results may not apply to all patients, and bleeding risks remain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cardiac lntensive Care Unit, First Department of Cardiology, University Clinical Centre in Gdańsk
RECRUITINGGdansk, Pomeranian Voivodeship, 80-214, Poland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••